Sector: Pharmaceuticals & Biotechnology

Small Cap

Brooks Laboratories Share Price

Q: What is the current share price of Brooks Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Brooks Laboratories Ltd. is ₹ 69.9 on the NSE and ₹ 71.8 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Brooks Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Brooks Laboratories Ltd. is approximately ₹ 207.7 Cr.

Q: What are the PE and PB ratios for Brooks Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Brooks Laboratories Ltd. is 8.4, and the Price-to-Book (PB) ratio is 1.7.

Q: What is the 52-Week High and Low for Brooks Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Brooks Laboratories Ltd. shares was ₹ 164.02, and the lowest price was ₹ 36.3.

Q: Who are the major shareholders of Brooks Laboratories Ltd.?

Significant shareholdings in Brooks Laboratories Ltd. typically include entities such as: Promoter Public Mutual Funds Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Brooks Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Brooks Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

BROOKS

₹69.90

-0.61(-0.87%)

10th Jul 2026 | 3:28 PM

NSE : BROOKS

Open Free Demat Account

Brooks Laboratories Performance

Price Movement

₹69.90

₹67.00

₹72.00

↘ Today's Low↗ Today's High

1 Year Performance

₹69.90

₹36.30

₹164.02

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹72.00

Low₹67.00

Open at₹72.00

Prev Close₹70.51

Volumes59.36 K

Avg Price₹69.03

Lower Circuit₹66.99

Upper Circuit₹74.03

Historical Performance

3M High₹79.69

3M Low₹44.56

1 Yr High₹164.02

1 Yr Low₹36.30

3 Yr High₹198.86

3 Yr Low₹36.30

5 Yr High₹198.86

5 Yr Low₹36.30

Summary

As of 10-07-2026 23:15, Brooks Laboratories Ltd. share price today is ₹0, with a change of ₹-70.51 (-100.00%) from the previous close of ₹70.51. The stock opened at ₹72 and traded between ₹67 and ₹72, with a total traded volume of 59356 shares. The company has a market capitalization of ₹207.7 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹164.02 and ₹36.3, respectively.

Brooks Laboratories Ltd. valuation metrics include a P/E ratio of 8.4, EPS of ₹8.35, and book value of ₹1.70. Profitability indicators show ROE of 20.04%. Brooks Laboratories Ltd. has reported revenue of ₹85.74 Cr and net profit of ₹24.58 Cr.

Brooks Laboratories Ltd. technical indicators include Day RSI at 52.29, Day MFI at 63.34, Day ADX at 34.39. Additional indicators include Commodity Channel Index (CCI) at -23.9 and Williams %R at -69.34. Momentum indicators show Day MACD at 2.6, Day MACD Signal Line at 3.15, DayATR at 4.13. Rate of Change indicators for Brooks Laboratories Ltd. include ROC125 at -8.74 and ROC21 at 3.34.

Exponential moving averages include EMA5 at ₹72.1, EMA10 at ₹72.2, EMA12 at ₹72, EMA20 at ₹70.6, EMA26 at ₹69.4, EMA50 at ₹66.5, EMA100 at ₹68.4, EMA200 at ₹80.7. Simple moving averages include SMA5 at ₹73.4, SMA10 at ₹72.8, SMA20 at ₹70.8, SMA30 at ₹69.2, SMA50 at ₹62.5, SMA100 at ₹63.2, SMA150 at ₹68.7, SMA200 at ₹81.7.

Support levels for Brooks Laboratories are placed at First Support ₹67.46, Second Support ₹64.40, Third Support ₹62.01. Resistance levels are seen at First Resistance ₹72.91, Second Resistance ₹75.30, Third Resistance ₹78.36. Brooks Laboratories Ltd. shareholding pattern shows promoter holding at 52.62%, FII holding at 0%, DII holding at 0%, public holding at 37%.

Brooks Laboratories Fundamentals

Market Cap

Below industry Median

207.70 Cr.

PE Ratio (TTM)

Low in industry

8.40

Dividend Yield

Net Profit TTM

298.1% incr over last year

24.58

Net Profit Growth

298.1% incr over last year

24.58

PEG Ratio

Below industry Median

ROE

297.4% incr over last year

20.04

Operating Revenue TTM

85.74

Operating Revenue Growth

15% decr over last year

Book Value

Below industry Median

1.70

MFI

MFI is mid-range

63.34

RSI

RSI is mid-range

52.29

EPS (TTM)

8.35

Debt to Equity

0.06

Face Value

Operating Profit Margin Qtr.

8.12

Operating Profit Qtr.

0.68

Net Profit Qtr.

1.52

Operating Revenue Qtr.

20.21

PB Ratio

1.70

Brooks Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	20.21	16.57	23.45	25.51	23.32
Operating Expense	19.53	15.83	20.93	22.38	21.74
Operating Profit	0.68	0.73	2.52	3.13	1.58
Depreciation	0.41	0.39	0.39	0.39	0.39
Interest	0.09	0.16	0.28	0.30	0.26
Tax	0	0	0	0	0.18
Net Profit	0.61	0.30	2.24	2.65	1.37

Brooks Laboratories Technicals

Brooks Laboratories Ltd. EMA & SMA

₹69.90

0.29 (0.42%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹72.1

Day EMA10 ₹72.2

Day EMA12 ₹72

Day EMA20 ₹70.6

Day EMA26 ₹69.4

Day EMA50 ₹66.5

Day EMA100 ₹68.4

Day EMA200 ₹80.7

Brooks Laboratories Support and Resistance

Resistance

First Resistance₹72.91

Second Resistance₹75.30

Third Resistance₹78.36

Support

First Support₹67.46

Second Support₹64.40

Third Support₹62.01

Technical Indicators

Day RSI52.29

Day MFI63.34

Day ADX34.39

Day Commodity Channel Index-23.90

William-69.34

Day MACD2.60

Day MACD Signal Line3.15

Day ATR4.13

Day ROC125-8.74

Day ROC213.34

Brooks Laboratories Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	52.6	52.6	52.6	52.6	52.6	52.6
FII	0	0	0	0.1	0.2	0
DII	10.4	10.4	10.4	10.4	10.4	10.4
Public	37	37	37	36.9	36.8	37

Brooks Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	32.98 K	32.98 K	100.00%
Week	37.44 K	37.44 K	100.00%
1 Month	41.7 K	41.7 K	100.00%
6 Month	69.79 K	1.14 L	61.14%

Brooks Laboratories SWOT Analysis

Strengths17

Weakness5

Opportunity0

Threats0

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Strong Performer, Under Radar Stocks (DVM)

Undervalued Growth Stocks

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Brooks Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Brooks Laboratories Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Valiant Laboratories Ltd.
Price (₹)	₹587.60	₹5.40	₹179.17	₹15.60	₹535	₹62
% Change	-1.43%	-0.18%	-2.00%	0.84%	-0.10%	-0.26%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	₹176.50	₹502.55	₹237.47
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	₹27.81	₹57.92	₹-3.28
PE TTM	-	-1.30	47.70	29.60	26.70	-103.00
1 Year Return	52.07	441	45.1	70	-25.38	-41.91
ROCE	3.56	-5.63	-	17.36	23.87	0.77

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 22.67

+1.98%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+0.50%

VINEETLAB

Vineet Laboratories Ltd.

₹ 32.80

+0.43%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 568.90

+0.36%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.62

-1.99%

MEDICO

Medico Remedies Ltd.

₹ 39.10

+0.03%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 195.49

+1.38%

LASA

Lasa Supergenerics Ltd.

₹ 7.52

+1.21%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 330.00

+1.74%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 345.50

-1.31%

ORTINGLOBE

Ortin Global Ltd.

₹ 16.50

+1.10%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2861.10

+7.69%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 204.61

+2.00%

ALPA

Alpa Laboratories Ltd.

₹ 68.70

+0.60%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 403.00

-0.99%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.21

-0.18%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.75

+1.80%

INDOCO

Indoco Remedies Ltd.

₹ 259.00

+1.53%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 247.05

+4.87%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 612.00

+0.01%

PANACEABIO

Panacea Biotec Ltd.

₹ 546.00

-1.66%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 244.00

-0.57%

THEMISMED

Themis Medicare Ltd.

₹ 117.59

+1.33%

FAQ's on BROOKS

What is the current share price of Brooks Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Brooks Laboratories Ltd. is ₹ 69.9 on the NSE and ₹ 71.8 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Brooks Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Brooks Laboratories Ltd. is approximately ₹ 207.7 Cr.

What are the PE and PB ratios for Brooks Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Brooks Laboratories Ltd. is 8.4, and the Price-to-Book (PB) ratio is 1.7.

What is the 52-Week High and Low for Brooks Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Brooks Laboratories Ltd. shares was ₹ 164.02, and the lowest price was ₹ 36.3.

Who are the major shareholders of Brooks Laboratories Ltd.?

Significant shareholdings in Brooks Laboratories Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Brooks Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Brooks Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy